These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15337519)

  • 21. Drug industry and chronobiology. Achievements and prospects.
    Carandente A; Halberg F
    Ann N Y Acad Sci; 1991; 618():484-9. PubMed ID: 2006802
    [No Abstract]   [Full Text] [Related]  

  • 22. Good pharma, bad pharma.
    Drug Ther Bull; 2013 Aug; 51(8):85. PubMed ID: 23927857
    [No Abstract]   [Full Text] [Related]  

  • 23. Extra-label drug use--pharmaceutical industry view.
    Welser JR
    J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract]   [Full Text] [Related]  

  • 24. A note on milligram potency and misleading promotion.
    Med Lett Drugs Ther; 1965 Mar; 7(6):24. PubMed ID: 5831355
    [No Abstract]   [Full Text] [Related]  

  • 25. Personalized medications.
    Koo V
    CMAJ; 2001 Nov; 165(11):1467-8. PubMed ID: 11762567
    [No Abstract]   [Full Text] [Related]  

  • 26. Proposed new classification system for topical medications according to "value".
    Diven DG; Poonawalla T
    J Am Acad Dermatol; 2007 Nov; 57(5):888-9. PubMed ID: 17939939
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutics for lymphatic disease: the role of the pharmaceutical and biotechnology sector.
    Rockson SG
    Lymphat Res Biol; 2005; 3(3):103-4. PubMed ID: 16190814
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemical substance and drug product.
    Marcus AD
    Am J Pharm Sci Support Public Health; 1969; 141(1):28-38. PubMed ID: 5776855
    [No Abstract]   [Full Text] [Related]  

  • 29. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-second report.
    World Health Organ Tech Rep Ser; 1992; 823():1-134. PubMed ID: 1462605
    [No Abstract]   [Full Text] [Related]  

  • 30. Data explosion fuels search for drugs.
    Wickware P
    Nature; 1999 Aug; 400(6746):799-800. PubMed ID: 10466732
    [No Abstract]   [Full Text] [Related]  

  • 31. The Cost of Pharmaceutical Company Detailing Visits and Medication Samples.
    Guglielmo BJ
    JAMA Intern Med; 2020 Apr; 180(4):595-596. PubMed ID: 31985770
    [No Abstract]   [Full Text] [Related]  

  • 32. The critical phase inspection process: a benchmarking study in search of industries' best practices.
    Herman DR; Dangler TL; Houser DA; Lewis TG; Masten JL; Taylor IE
    Qual Assur; 1993; 2(1-2):186-90. PubMed ID: 8156211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repackaging.
    Prescrire Int; 2016 Jan; 25(167):10. PubMed ID: 26942252
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacogenetics and drug metabolism.
    Ball S; Borman N
    Nat Biotechnol; 1997 Oct; 15(10):925-6. PubMed ID: 9335033
    [No Abstract]   [Full Text] [Related]  

  • 35. Current practices for DNA sample collection and storage in the pharmaceutical industry, and potential areas for harmonization: perspective of the I-PWG.
    Franc MA; Warner AW; Cohen N; Shaw PM; Groenen P; Snapir A
    Clin Pharmacol Ther; 2011 Apr; 89(4):546-53. PubMed ID: 21368755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription and proscription.
    Ingelfinger FJ; Elia JJ
    N Engl J Med; 1971 Nov; 285(21):1199-201. PubMed ID: 5096644
    [No Abstract]   [Full Text] [Related]  

  • 37. An industry survey on current practices in the design and analysis of active control studies.
    Chuang-Stein C; Sanders C; Snapinn S
    J Biopharm Stat; 2004 May; 14(2):349-58. PubMed ID: 15206532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Back on target.
    Webb S
    Nat Biotechnol; 2013 Mar; 31(3):191-3. PubMed ID: 23471062
    [No Abstract]   [Full Text] [Related]  

  • 39. [Precision and accuracy in production processes].
    Cattaneo A; Merli S
    Boll Chim Farm; 1969 Mar; 108(3):145-51. PubMed ID: 5806404
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of Caco-2 cell monolayer drug transport properties by cassette dosing using UV/fluorescence HPLC.
    Palmgrén JJ; Mönkkönen J; Jukkola E; Niva S; Auriola S
    Eur J Pharm Biopharm; 2004 Mar; 57(2):319-28. PubMed ID: 15018991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.